Search Results - "Lin, Tai An"
-
1
Current and emerging therapies for Achondroplasia: The dawn of precision medicine
Published in Bioorganic & medicinal chemistry (03-05-2023)“…[Display omitted] Achondroplasia is a rare disease affecting bone growth and is caused by a missense mutation in the fibroblast growth factor receptor 3…”
Get full text
Journal Article -
2
CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression
Published in The Journal of immunology (1950) (01-06-2017)“…The inflammatory CD40-CD40L pathway is implicated in various autoimmune diseases, but the activity status of this pathway in various stages of rheumatoid…”
Get full text
Journal Article -
3
Discovery of siRNA Lipid Nanoparticles to Transfect Suspension Leukemia Cells and Provide In Vivo Delivery Capability
Published in Molecular therapy (01-02-2014)“…As a powerful research tool, siRNA's therapeutic and target validation utility with leukemia cells and long-term gene knockdown is severely restricted by the…”
Get full text
Journal Article -
4
Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors
Published in Molecular cancer therapeutics (01-11-2008)“…In developing inhibitors of the LIM kinases, the initial lead molecules combined potent target inhibition with potent cytotoxic activity. However, as…”
Get full text
Journal Article -
5
RG7212 Anti-TWEAK mAb Inhibits Tumor Growth through Inhibition of Tumor Cell Proliferation and Survival Signaling and by Enhancing the Host Antitumor Immune Response
Published in Clinical cancer research (15-10-2013)“…To explore the role of TWEAK in tumor growth and antitumor immune response and the activity and mechanism of RG7212, an antagonistic anti-TWEAK antibody, in…”
Get full text
Journal Article -
6
Preclinical Characterization of Linrodostat Mesylate, a Novel, Potent, and Selective Oral Indoleamine 2,3-Dioxygenase 1 Inhibitor
Published in Molecular cancer therapeutics (01-03-2021)“…Tumors can exploit the indoleamine 2,3-dioxygenase 1 (IDO1) pathway to create an immunosuppressive microenvironment. Activated IDO1 metabolizes tryptophan into…”
Get full text
Journal Article -
7
Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function
Published in Nature (London) (27-10-1994)“…The cloning is described of two related human complementary DNAs encoding polypeptides that interact specifically with the translation initiation factor…”
Get full text
Journal Article -
8
The Rapamycin-Binding Domain Governs Substrate Selectivity by the Mammalian Target of Rapamycin
Published in Molecular and Cellular Biology (01-11-2002)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
9
PHAS-I as a Link Between Mitogen-Activated Protein Kinase and Translation Initiation
Published in Science (American Association for the Advancement of Science) (28-10-1994)“…PHAS-I is a heat-stable protein (relative molecular mass $\approx$12,400) found in many tissues. It is rapidly phosphorylated in rat adipocytes incubated with…”
Get full text
Journal Article -
10
Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1
Published in Bioorganic & medicinal chemistry letters (15-05-2023)“…[Display omitted] Starting from the dialkylaniline indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor lead 3 (IDO1 HeLa IC50 = 7.0 nM), an iterative process of…”
Get full text
Journal Article -
11
Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1
Published in ACS medicinal chemistry letters (11-02-2021)“…Indoleamine 2,3-dioxygenase 1 (IDO1) is a heme-containing dioxygenase enzyme implicated in cancer immune response. This account details the discovery of…”
Get full text
Journal Article -
12
Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy
Published in ACS medicinal chemistry letters (11-03-2021)“…Indoleamine 2,3-dioxygenase 1 (IDO1) has been identified as a target for small-molecule immunotherapy for the treatment of a variety of cancers including renal…”
Get full text
Journal Article -
13
Control of the Translational Regulators PHAS-I and PHAS-II by Insulin and cAMP in 3T3-L1 Adipocytes
Published in The Journal of biological chemistry (22-11-1996)“…The eukaryotic initiation factor 4E (eIF-4E)-binding proteins PHAS-I and PHAS-II were found to have overlapping but different patterns of expression in…”
Get full text
Journal Article -
14
KU812 cells provide a novel in vitro model of the human IL-33/ST2L axis: Functional responses and identification of signaling pathways
Published in Experimental cell research (10-09-2010)“…Activation of interleukin-1 family receptor ST2L by its ligand interleukin-33 (IL-33) is an important component in inflammatory responses. Peripheral blood…”
Get full text
Journal Article -
15
Conformational-Analysis-Guided Discovery of 2,3-Disubstituted Pyridine IDO1 Inhibitors
Published in ACS medicinal chemistry letters (08-07-2021)“…IDO1 inhibitors have shown promise as immunotherapies for the treatment of a variety of cancers, including metastatic melanoma and renal cell carcinoma. We…”
Get full text
Journal Article -
16
The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens
Published in BMC cell biology (24-01-2008)“…A crucial event in Prostate Cancer progression is the conversion from a hormone-sensitive to a hormone-refractory disease state. Correlating with this…”
Get full text
Journal Article -
17
Modulation of cofilin phosphorylation by inhibition of the Lim family kinases
Published in Bioorganic & medicinal chemistry letters (15-09-2012)“…The design, synthesis, and SAR for a series of aminothiazole pyrimidines as potent LIMK inhibitors are described. Compound 31 effectively inhibited cofilin…”
Get full text
Journal Article -
18
Discovery of a 1H-Benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity
Published in Journal of medicinal chemistry (08-09-2005)“…Compound 3 (BMS-536924), a novel small-molecule inhibitor of the insulin-like growth factor receptor kinase with equal potency against the insulin receptor is…”
Get full text
Journal Article -
19
Selective Itk Inhibitors Block T-Cell Activation and Murine Lung Inflammation
Published in Biochemistry (Easton) (31-08-2004)“…Nonreceptor protein tyrosine kinases including Lck, ZAP-70, and Itk play essential roles in T-cell receptor (TCR) signaling. Gene knockout studies have…”
Get full text
Journal Article -
20
Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors
Published in Bioorganic & medicinal chemistry letters (15-07-2006)“…A series of structurally novel aminothiazole based small molecule inhibitors of Itk were prepared to elucidate their structure–activity relationships (SARs),…”
Get full text
Journal Article